Tatjana Becker

Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Comparing apples and pears? Evaluating the interchangeability of three different positions for hip abduction and adduction strength testing in academy footballers.

Comparing apples and pears? Evaluating the interchangeability of three different positions for hip abduction and adduction strength testing in academy footballers.

Journal: Journal of athletic training
Published: March 10, 2025

Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms.

Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms.

Journal: Hamostaseologie
Published: October 09, 2023

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET.

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET.

Journal: HemaSphere
Published: December 28, 2022

Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN.

Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN.

Journal: Leukemia
Published: November 17, 2021

Bleeding complications in bcr-abl-negative myeloproliferative neoplasms (MPN): A retrospective single-center study of 829 MPN patients.

Bleeding complications in bcr-abl-negative myeloproliferative neoplasms (MPN): A retrospective single-center study of 829 MPN patients.

Journal: European journal of haematology
Published: June 10, 2021

Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies.

Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies.

Journal: Annals of hematology
Published: April 21, 2021

The management, outcome, and postpartum disease course of 41 pregnancies in 20 women with polycythemia vera.

The management, outcome, and postpartum disease course of 41 pregnancies in 20 women with polycythemia vera.

Journal: European journal of haematology
Published: January 21, 2021

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.

Journal: Annals of hematology
Published: November 03, 2020

Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.

Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.

Journal: Journal of cancer research and clinical oncology
Published: August 10, 2020

Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN.

Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN.

Journal: Leukemia
Published: May 27, 2020

High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation.

High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation.

Journal: Annals of hematology
Published: April 22, 2018

Beer and beer compounds: physiological effects on skin health.

Beer and beer compounds: physiological effects on skin health.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 28, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026